Document Detail


Transesophageal echo to help percutaneous closure of ventricular septal defect post acute myocardial infarction.
MedLine Citation:
PMID:  21526918     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Ventricular septal defect after acute myocardial infarction (AMI) is a complication associated with poor outcome in the absence of intervention. We report a case of successful TEE guided transcatheter closure of a post myocardial infarction (MI) ventricular septal defect (VSD) with an Amplatzer occluder in a 79 years old male with cardiogenic shock.
Authors:
Ilie T Barb; Collins A Kwarteng; Peter Block; Douglas C Morris; Stamatios Lerakis
Related Documents :
1892058 - Thrombolysis in refractory unstable angina.
1576858 - Rationale of exercise therapy in patients with angina pectoris with normal and impaired...
17203338 - Vasospastic angina in a 13-year-old female patient whose only symptom was toothache.
1359258 - Effect of enalapril on myocardial infarction and unstable angina in patients with low e...
20462338 - Early therapy following myocardial infarction: arguments for and against implantable ca...
11406478 - In vivo assessment of acetylcholine-releasing function at cardiac vagal nerve terminals.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-28
Journal Detail:
Title:  Acute cardiac care     Volume:  -     ISSN:  1748-295X     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101276603     Medline TA:  Acute Card Care     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Cardiology, Emory University Hospital, Atlanta, Georgia, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Outcomes of acute heart failure associated with acute coronary syndrome versus other causes.
Next Document:  Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary perc...